A component of ayahuasca has demonstrated therapeutic effects in experimental models of Parkinson's, in turn succeeding in avoiding the hallucinogenic effects of Amazonian drink, as revealed by research led by the Complutense University of Madrid (UCM).
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
A component of ayahuasca has demonstrated therapeutic effects in experimental models of Parkinson's, in turn succeeding in avoiding the hallucinogenic effects of Amazonian drink, as revealed by research led by the Complutense University of Madrid (UCM).